Análise de eficácia de acordo com valores de TMB no CheckMate 9LA

O tumor mutation burden (TMB) está potencialmente associado à eficácia clínica dos inibidores de correceptores imunes. Durante o ELCC 2022, foram apresentados os dados de eficácia da combinação de nivolumabe + ipilimumabe + quimioterapia segundo os valores de TMB tanto do tecido tumoral quanto do sangue dos pacientes.

Arquivos #oncologiabrasil - Página 79 de 173 - Oncologia Brasil

Arquivos #oncologiabrasil - Página 79 de 173 - Oncologia Brasil

H. Jack West, MD on X: Long-awaited results of CheckMate-9LA, nivo/ipi w/2 cycles of chemo vs. ctrl arm of 4 cycles chemo is pos for OS benefitbut that's impressive for 2017, not

Ana Moreno (@superanitamix) / X

PDF) TERAPIA FOTODINÂMICA ATIVADA POR RAIOS X POR INTERMÉDIO DE NANOPARTÍCULAS CINTILADORAS: REVISÃO INTEGRATIVA, Revista Portuguesa de Oncologia

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial - The Lancet Oncology

First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes - ScienceDirect

H. Jack West, MD on X: Long-awaited results of CheckMate-9LA, nivo/ipi w/2 cycles of chemo vs. ctrl arm of 4 cycles chemo is pos for OS benefitbut that's impressive for 2017, not

Arquivo de GBCP - GBCP

PDF) Oncogene addiction and tumor mutational burden in non-small-cell lung cancer: Clinical significance and limitations: Tumor mutational burden in NSCLC

Arquivos Câncer de pulmão - Página 11 de 29 - Oncologia Brasil

Arquivos Câncer de pulmão - Página 11 de 29 - Oncologia Brasil

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA

Arquivo de GBCP - GBCP